People · Operator

Liam S. Ratcliffe

Named in public records as an officer, director or promoter · active 2009–2009 · Other Health Care

1
Companies
2
Filings
$58.1M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Afferent Pharmaceuticals, Inc.Other Health CareSeries C$58.1M$1.3B2009
Operator network

Liam S. Ratcliffe at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

David Neafus · 7 companies · 1 sharedDavid NeafusMitchell S. Bloom · 7 companies · 1 sharedMitchell S. BloomKevin Starr · 5 companies · 1 sharedKevin StarrKathleen Sereda Glaub · 3 companies · 1 sharedKathleen Sereda G…Arthur S. Pappas · 2 companies · 1 sharedArthur S. PappasLiam Sereda Ratcliffe · 2 companies · 1 sharedLiam Sereda Ratcl…Peter Sereda Hirth · 2 companies · 1 sharedPeter Sereda HirthAnthony Sereda Ford · 1 companies · 1 sharedAnthony Sereda Fo…Arthur Sereda Pappas · 1 companies · 1 sharedArthur Sereda Pap…Jesse Sereda Treu · 1 companies · 1 sharedJesse Sereda TreuJesse S. Treu · 1 companies · 1 sharedJesse S. TreuKevin Sereda Starr · 1 companies · 1 sharedKevin Sereda StarrMichael Sereda Kitt · 1 companies · 1 sharedMichael Sereda Ki…Afferent Pharmaceuticals, Inc. · $58.1M raisedAfferent Pharmaceutic…Liam S. RatcliffeLR
Liam S. Ratcliffe Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Liam S. Ratcliffe on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Mitchell S. Bloom17
David Neafus17
Kevin Starr15
Kathleen Sereda Glaub13
Liam Sereda Ratcliffe12
Arthur S. Pappas12
Peter Sereda Hirth12
Jesse Sereda Treu11
Kevin Sereda Starr11
Michael Sereda Kitt11
Arthur Sereda Pappas11
Anthony Sereda Ford11
Jesse S. Treu11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.